Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Normative reference values of joint space width estimated by computer-aided joint space analysis (CAJSA): the distal interphalangeal joint.
Pfeil A, Böttcher J, Schäfer ML, Seidl BE, Schmidt M, Petrovitch A, Heyne JP, Lehmann G, Oelzner P, Hein G, Wolf G, Kaiser WA. Pfeil A, et al. Among authors: schmidt m. J Digit Imaging. 2008 Oct;21 Suppl 1(Suppl 1):104-12. doi: 10.1007/s10278-007-9031-x. Epub 2007 Mar 24. J Digit Imaging. 2008. PMID: 17384977 Free PMC article.
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.
Feldstein LR, Ruffin J, Wiegand RE, Borkowf CB, James-Gist J, Babu TM, Briggs-Hagen M, Chappell J, Chu HY, Englund JA, Kuntz JL, Lauring AS, Lo N, Carone M, Lockwood C, Martin ET, Midgley CM, Monto AS, Naleway AL, Ogilvie T, Saydah S, Schmidt MA, Schmitz JE, Smith N, Sohn I, Starita L, Talbot HK, Weil AA, Grijalva CG. Feldstein LR, et al. Among authors: schmidt ma. J Infect Dis. 2025 Jan 8:jiaf007. doi: 10.1093/infdis/jiaf007. Online ahead of print. J Infect Dis. 2025. PMID: 39774936
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Lopez J, Powles T, Braiteh F, Siu LL, LoRusso P, Friedman CF, Balmanoukian AS, Gordon M, Yachnin J, Rottey S, Karydis I, Fisher GA, Schmidt M, Schuler M, Sullivan RJ, Burris HA, Galvao V, Henick BS, Dirix L, Jaeger D, Ott PA, Wong KM, Jerusalem G, Schiza A, Fong L, Steeghs N, Leidner RS, Rittmeyer A, Laurie SA, Gort E, Aljumaily R, Melero I, Sabado RL, Rhee I, Mancuso MR, Muller L, Fine GD, Yadav M, Kim L, Leveque VJP, Robert A, Darwish M, Qi T, Zhu J, Zhang J, Twomey P, Rao GK, Low DW, Petry C, Lo AA, Schartner JM, Delamarre L, Mellman I, Löwer M, Müller F, Derhovanessian E, Cortini A, Manning L, Maurus D, Brachtendorf S, Lörks V, Omokoko T, Godehardt E, Becker D, Hawner C, Wallrapp C, Albrecht C, Kröner C, Tadmor AD, Diekmann J, Vormehr M, Jork A, Paruzynski A, Lang M, Blake J, Hennig O, Kuhn AN, Sahin U, Türeci Ö, Camidge DR. Lopez J, et al. Among authors: schmidt m. Nat Med. 2025 Jan 6. doi: 10.1038/s41591-024-03334-7. Online ahead of print. Nat Med. 2025. PMID: 39762422
10,331 results
You have reached the last available page of results. Please see the User Guide for more information.